Procter & Gamble Health Limited (BOM:500126)
India · Delayed Price · Currency is INR 5,817.45
-116.25 (-1.96%)
At close: Aug 17, 2026
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 96.57 billion as of August 17, 2026. Its market cap has decreased by -7.47% in one year.
Market Cap
96.57B
Enterprise Value
94.81B
Revenue
14.33B
Ranking
n/a
PE Ratio
30.63
Stock Price
5,817.45
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 96.57B, an increase of 890.85%. That is a compound annual growth rate of 8.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 96.57B | 2.04% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 212.63B |
| AstraZeneca Pharma India | 193.84B |
| Caplin Point Laboratories | 188.55B |
| Jubilant Pharmova | 136.92B |
| CORONA Remedies | 130.71B |
| Viyash Scientific | 111.56B |
| Sanofi India | 74.77B |
| FDC Limited | 57.68B |